Implantable arterial port-related bloodstream infection in patients with primary or metastatic hepatic malignancies

被引:0
|
作者
Honda, Hitoshi [1 ]
Sakurai, Yasuo [2 ]
Kang, Jong-Hon [3 ]
Nakamura, Tadahiro [1 ]
Matsuura, Hirotaka [1 ]
Warren, David K. [4 ]
机构
[1] Teine Keijinkai Med Ctr, Dept Gen Internal Med & Infect Dis, Sapporo, Hokkaido 0068555, Japan
[2] Teine Keijinkai Med Ctr, Dept Radiol, Sapporo, Hokkaido 0068555, Japan
[3] Teine Keijinkai Med Ctr, Ctr Gastroenterol, Sapporo, Hokkaido 0068555, Japan
[4] Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO 63110 USA
关键词
Implantable arterial port; Hepatic malignancies; Port-related bloodstream infection; HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; LIVER METASTASES; CHEMOTHERAPY; INFUSION;
D O I
10.1016/j.ajic.2013.01.018
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The incidence of implantable arterial post-related bloodstream infections (IAP-RBSI) among patients with unresectable hepatic malignancies is not well defined. We reviewed the 9-year incidence of implantable arterial post-related bloodstream infections in patients with hepatic malignancies, at a tertiary care center in Japan. The incidence was 1.9 infections per 10,000 catheter-days. Copyright (C) 2013 by the Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:930 / 932
页数:3
相关论文
共 50 条
  • [1] Port-related Streptococcus pneumoniae bloodstream infection
    del Pozo, Jose Luis
    Santisteban, Marta
    Alonso, Marta
    Hernaez, Silvia
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2007, 25 (05): : 359 - 360
  • [2] Incidence of Implantable Central Venous Access Port-Related Infection in Cancer Patients
    Ling, J.
    Martin, H.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 63 - 64
  • [3] Percutaneous implantable port-related infection and thrombosis: diagnostic and management
    Noel-Savina, Elise
    Quere, Gilles
    Gouva, Sylvie
    Robinet, Gilles
    Descourt, Renaud
    BULLETIN DU CANCER, 2011, 98 (09) : 1107 - 1118
  • [4] Implantable venous port-related infections in cancer patients
    Huang, WT
    Chen, TY
    Su, WC
    Yen, CJ
    Tsao, CJ
    SUPPORTIVE CARE IN CANCER, 2004, 12 (03) : 197 - 201
  • [5] Implantable venous port-related infections in cancer patients
    Wen-Tsung Huang
    Tsai-Yun Chen
    Wu-Chou Su
    Chia-Jui Yen
    Chao-Jung Tsao
    Supportive Care in Cancer, 2004, 12 : 197 - 201
  • [6] Using Hepac Lock Flush for reducing Port-related bloodstream infection
    Tsai, Shu-Jiuan
    Tsai, Chen-Chi
    Lay, Chorng-Jang
    Chuang, Hui-Ying
    Chen, Ya-Lan
    Lin, Lin-Jia
    Su, Hsiu-Lun
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S135 - S135
  • [7] Is diabetes a risk factor for central venous access port-related bloodstream infection in oncological patients?
    A. Touré
    P. Vanhems
    C. Lombard-Bohas
    J.-C. Souquet
    M. Lauverjat
    C. Chambrier
    European Journal of Clinical Microbiology & Infectious Diseases, 2013, 32 : 133 - 138
  • [8] Is diabetes a risk factor for central venous access port-related bloodstream infection in oncological patients?
    Toure, A.
    Vanhems, P.
    Lombard-Bohas, C.
    Souquet, J. -C.
    Lauverjat, M.
    Chambrier, C.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2013, 32 (01) : 133 - 138
  • [9] Dispersin B therapy of Staphylococcus aureus experimental port-related bloodstream infection
    Serrera, A.
    del Pozo, J. L.
    Martinez, A.
    Alonso, M.
    Gonzalez, R.
    Leiva, J.
    Vergara, M.
    Lasa, I.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S508 - S508
  • [10] A Case-Control Study to Identify Risk Factors for Totally Implantable Central Venous Port-Related Bloodstream Infection
    Lee, Guk Jin
    Hong, Sook Hee
    Roh, Sang Young
    Park, Sa Rah
    Lee, Myung Ah
    Chun, Hoo Geun
    Hong, Young Seon
    Kang, Jin Hyoung
    Kim, Sang Il
    Kim, Youn Jeong
    Chun, Ho Jong
    Oh, Jung Suk
    CANCER RESEARCH AND TREATMENT, 2014, 46 (03): : 250 - 260